Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Imaging drug <68>Ga-NOTA-IF7 targeting Anxa1 in tumor blood vessels and preparation method thereof

A technology of NOTA-IF7 and 68ga-nota-if7, applied in material separation, instruments, analytical materials, etc., can solve problems such as high negative predictive value, and achieve the effects of short time consumption, simple preparation process and stable markers

Inactive Publication Date: 2014-06-04
JIANGSU INST OF NUCLEAR MEDICINE
View PDF0 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the uptake of FDG is not unique to tumor tissues, and can also be concentrated in normal tissues such as the heart and brain. In addition, inflammation, sarcoid tumors, tuberculosis, and urinary tracts also have more FDG concentrations, so there are also certain false positives. but have a high negative predictive value

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Imaging drug &lt;68&gt;Ga-NOTA-IF7 targeting Anxa1 in tumor blood vessels and preparation method thereof
  • Imaging drug &lt;68&gt;Ga-NOTA-IF7 targeting Anxa1 in tumor blood vessels and preparation method thereof
  • Imaging drug &lt;68&gt;Ga-NOTA-IF7 targeting Anxa1 in tumor blood vessels and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Example 1 68 Ga leaching

[0034] Use a 5mL syringe to take 5mL of 0.05mol / L HCl to rinse the germanium-gallium generator at a rate of 1-2mL / min, and collect the eluent at the same time, 1mL per bottle. Take the vial with the highest radioactivity for labeling.

Embodiment 2

[0035] Example 2 68 Labeling of Ga-NOTA-IF7

[0036] Dissolve NOTA-IF7 with DMSO, take 30μL NOTA-IF7 (10μg~100μg), add 300μL freshly rinsed 68 Ga (7.4~740MBq), adjust the pH to 3.5~4.5 with 1mol / L Hepes buffer, shake and mix gently, and react in a water bath at 50~100°C for 10~20min to obtain the product radioactivity 68 Ga-NOTA-IF7.

[0037] A preparation method targeting tumor blood vessel Anxa1 labeled precursor NOTA-IF 7, the steps are as follows:

[0038] (1) Dissolution: Weigh 8 mg of p-SCN-Bn-NOTA and dissolve in 50 μL dimethyl sulfoxide DMSO to obtain solution a; weigh 20 mg IF 7 and dissolve in 300 μL dimethylformamide DMF to obtain solution b;

[0039] (2) Preparation of NOTA-IF 7: Add solution a and solution b prepared in step (1) into a glass bottle according to the mass ratio of NOTA:IF7 1-2:1, and then add 50 μL of diisopropylethylamine DIEA , react at 40°C for 2 h; cool to room temperature, add 30 μL of acetic acid to the reaction solution to terminate the rea...

Embodiment 3

[0043] Embodiment 3 quality control

[0044] 68 Radioactivity purity of Ga-NOTA-IF7 was determined by HPLC.

[0045] HPLC analysis conditions: chromatographic analysis column is C18 column (4.6×250mm), injection volume is 10μL, mobile phase A is pure water containing 0.1% TFA, B is acetonitrile containing 0.1% TFA, flow rate is 1mL / min, gradient wash The stripping condition was 95% A and 5% B at 5 minutes, increased to 35% A and 65% B at 30 minutes, and the detection wavelength was 218nm. For radioactivity detection, use a special radioactive detector for HPLC, see the results figure 1 .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Login to View More

Abstract

The invention belongs to the fields of radiopharmaceuticals and nuclear medicine and provides an imaging drug <68>Ga-NOTA-IF7 targeting Anxa1 in tumor blood vessels and a preparation method thereof. The drug <68>Ga-NOTA-IF7 is used for differential diagnosis and periodization of tumors, accurate positioning of focuses and curative effect monitoring. According to the invention, the tumor imaging drug <68>Ga-NOTA-IF7 is prepared through leaching of <68>Ga and <68>Ga-NOTA-IF7 labeling. The preparation method has the advantages of simple preparation technology, convenient operation, small consumption of time, a high labeling rate and a stable marker and facilitates further application of the drug in clinical practice, scientific research and medicinal development. The invention also provides a novel positive electron tumor imaging agent. The novel positive electron tumor imaging agent has good targeting to tumors, so tumor imaging effects are improved, and a visual tool is provided for differential diagnosis and periodization of tumors, accurate positioning of focuses and curative effect monitoring. <68>Ga-NOTA-IF7 is a labeled compound belonging to polypeptide and has the advantages of small molecular weight, low immunogenicity, good tissue penetrability, high tumor tissue affinity and good application prospects.

Description

technical field [0001] An imaging drug targeting tumor blood vessels Anxa1 68 Ga-NOTA-IF7 and a preparation method thereof are used for differential diagnosis, staging, precise location of lesion and curative effect monitoring of tumors, and belong to the fields of radiopharmaceuticals and nuclear medicine. Background technique [0002] In recent years, with the penetration of molecular biology into the field of nuclear medicine and the development of PET / CT technology, but due to the lag in the development of radiopharmaceuticals, the bottleneck of PET / CT application has become prominent. At present, in all the examinations of PET imaging in my country, more than 95% of PET drugs are 18 F-labeled 2-fluorodeoxyglucose ( 18 F-FDG), greatly limiting the potential functions and effects of PET. Therefore, the study of new positron radionuclides and their labeled radiopharmaceuticals has become a hot spot in the development of nuclear medicine. [0003] The application of rad...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K51/08G01N30/02
Inventor 蒋孟军顾晓波蔡刚明张荣军黄荷云潘栋辉张波
Owner JIANGSU INST OF NUCLEAR MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com